Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature.

"Ten key papers published over the last 10 years were identified with seven intervention studies reporting that ALA from nut and seed oils was not converted to DHA at all. Three studies showed that ingestion of micro-algae oil led to significant increases in blood erythrocyte and plasma DHA. Further work is now needed to identify optimal doses of alternative vegetarian LC3PUFAs and how these can be integrated within daily diets. The potential role of algal oils appears to be particularly promising and an area in which further research is warranted."

https://www.ncbi.nlm.nih.gov/pubmed/24261532

[Study of DHA algal oil compound preparation on improving memory in mice].

"DHA algal oil compound preparation may play an important role in memory improvement in mice."

https://www.ncbi.nlm.nih.gov/pubmed/25958644

Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.

"Clinical trials with DHA-rich oil indicate comparable efficacies to fish oil for protection from cardiovascular risk factors by lowering plasma triglycerides and oxidative stress."

https://www.ncbi.nlm.nih.gov/pubmed/18220672

Safety assessment of DHA-rich microalgae from Schizochytrium sp.

The purpose of this series of studies was to assess the genotoxic potential of docosahexaenoic acid-rich microalgae from Schizochytrium sp. (DRM). DRM contains oil rich in highly unsaturated fatty acids (PUFAs). DRM was not clastogenic to human peripheral blood lymphocytes in culture. Additionally, DRM did not induce micronucleus formation in mouse bone marrow in vivo further supporting its lack of any chromosomal effects. Overall, the results of this series of mutagenicity assays support the conclusion that DRM does not have any genotoxic potential."

https://www.ncbi.nlm.nih.gov/pubmed/12052009

Safety assessment of DHA-rich microalgae from Schizochytrium sp.

https://www.ncbi.nlm.nih.gov/pubmed/11350203

FOR THE HARDCORE MITOCHONDRIACS: IS MITOLIFE CHROMISTA IN THE SN-2 POSITION? YES.

A Novel Phosphatidylcholine Which Contains Pentadecanoic Acid at Sn-1 and Docosahexaenoic Acid at Sn-2 in Schizochytrium Sp. F26-B

https://www.ncbi.nlm.nih.gov/labs/articles/16829536/

 Note: Schizochytrium is the species of algae used in MITOLIFE Chromista DHA.